Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis 2008 Dec 15;47(12):e97-9

Date

11/11/2008

Pubmed ID

18991509

Pubmed Central ID

PMC2941349

DOI

10.1086/593314

Scopus ID

2-s2.0-56749153964 (requires institutional sign-in at Scopus site)   37 Citations

Abstract

We report the first case of a human immunodeficiency virus type 1 (HIV-1)-infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed Cushing syndrome with profound complications after epidural triamcinolone injections. This case highlights the potential of ritonavir interactions even with local injections of a corticosteroid.

Author List

Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F

Author

Kristin Busse PharmD Assistant Professor in the School of Pharmacy Administration department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Cushing Syndrome
Drug Interactions
HIV Infections
HIV-1
Humans
Iatrogenic Disease
Lopinavir
Male
Pyrimidinones
Ritonavir
Triamcinolone